Slide Team
Interim Chief Executive Officer of Ziopharm

Heidi Hagan

Ms. Hagen is currently the Interim Chief Executive Officer of Ziopharm. She has served on the Board of Ziopharm since June 2019 and the Board of Vericel since 2013.

She is a 30-year veteran of the biotechnology industry, the last 20 in cell and gene therapy. Ms. Hagen is co-founder of Vineti, a cloud-based software platform company that addresses challenges in data management from order through cell collection, manufacturing, and delivery of personalized treatments such as cell and gene therapies and cancer vaccines. She has extensive experience in operations management and commercializing innovative technologies. She is also the former Global COO for SOTIO a.s. and the Senior Vice President of Operations for Dendreon. Ms. Hagen has a B.S. in Cell and Molecular Biology, an MS in Bioengineering, and an MBA from the University of Washington.